Back to Search
ALFRED GARCIA, M.D.
M.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1871884569IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
A119403(CA)
CMS Specialties
PrimaryPATHOLOGY
Education
OTHER
Class of 2010
Research & Publications (20)
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.
PMID 18165643·J Clin Oncol·2008
3-trial
A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial carcinoma: a study by the Gynecologic Oncology Group.
PMID 18675446·Gynecol Oncol·2008
3-trial
Phase I clinical trial of weekly docetaxel and exisulind, a novel inducer of apoptosis.
PMID 16379039·Invest New Drugs·2006
3-trial
Phase II clinical trial of capecitabine in ovarian carcinoma recurrent 6-12 months after completion of primary chemotherapy, with exploratory TS, DPD, and TP correlates: a Gynecologic Oncology Group study.
PMID 15721430·Gynecol Oncol·2005
3-trial
Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule.
PMID 15809878·Cancer Chemother Pharmacol·2005
3-trial
Phase I clinical trial of topotecan and pegylated liposomal doxorubicin.
PMID 16377584·Cancer Invest·2005
3-trial
GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain.
PMID 15494728·Nat Neurosci·2004
4-observational
Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer.
PMID 15099968·Gynecol Oncol·2004
3-trial
Phase II clinical trial of 5-fluorouracil, trimetrexate, and leucovorin (NFL) in patients with advanced pancreatic cancer.
PMID 15361639·Int J Gastrointest Cancer·2003
3-trial
Phase I escalation of gemcitabine combined with protracted oral etoposide in gynecologic malignancies: A Gynecologic Oncology Group study.
PMID 12448655·Invest New Drugs·2002
3-trial
Phase II trial of outpatient schedule of paclitaxel in patients with previously untreated metastatic, measurable adenocarcinoma of the stomach.
PMID 11463806·Jpn J Clin Oncol·2001
3-trial
Phase I and pharmacologic study of i.v. hydroxyurea infusion given with i.p. 5-fluoro-2'-deoxyuridine and leucovorin.
PMID 11459996·Anticancer Drugs·2001
3-trial
Effects of supported lipid monolayer fluidity on the adhesion of hematopoietic progenitor cell lines to fibronectin-derived peptide ligands for alpha5beta1 and alpha4beta1 integrins.
PMID 19437769·Langmuir·2009
8-other
Adverse effects of propafenone after long-term therapy with the addition of citalopram.
PMID 18675768·Am J Geriatr Pharmacother·2008
5-case
The infrared spectrum of solid L-alanine: influence of pH-induced structural changes.
PMID 18707059·J Phys Chem A·2008
8-other
Quantitative trait loci mapping and the genetic basis of heterosis in maize and rice.
PMID 18791260·Genetics·2008
8-other
Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.
PMID 18852242·Infect Immun·2008
7-preclinical
Growth and lipid composition of Atlantic cod (Gadus morhua) larvae in response to differently enriched Artemia franciscana.
PMID 18649026·Fish Physiol Biochem·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1200 N STATE ST, PATHOLOGY, CLINIC TOWER A7E
LOS ANGELES, CA 90033 - Phone
- (323) 409-7148
Quick Facts
- NPI
- 1871884569
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile